Literature DB >> 18577650

Immune cells in the human choroid.

M-K Ezzat1, C R Hann, S Vuk-Pavlovic, J S Pulido.   

Abstract

AIM: To characterise the leucocytes in human macular choroid with and without drusen, and in eyes with advanced age-related macular degeneration (AMD) with fibrovascular scarring (FVS).
METHODS: Ten eyes from nine donors (range 55-91 years of age) were obtained from an eye bank within 38 h post mortem. Fixed macular biopsies were sectioned, stained immunochemically and examined for the presence of leucocyte antigens CD45, CD4, CD8, CD14 and CD83.
RESULTS: Four eyes without drusen, four eyes with drusen and two eyes with FVS contained 23.9 (SD 6.2)%, 27.5 (7.2)%, and 19.3 (11.3)% CD45-positive cells, respectively. The corresponding percentages for CD4-positive cells were 5.4 (4.3), 8.9 (3.0) and 7.5 (8.1); for CD8-positive cells, 3.8 (0.7), 6.8 (2.2) and 6.3 (2.1); and for CD14-positive cells, 3.7 (3.7), 3.6 (1.6) and 2.6 (3.6), respectively. The authors found CD83-positive cells solely in one of the two FVS eyes examined that had the more severe form of scarring.
CONCLUSION: Human choroid contains similar amounts of CD4-positive cells and monocytes irrespective of the presence of drusen, but CD8-positive cells are more abundant in macular choroid with drusen. The presence of haematopoietic cells in the macular choroid provides further evidence for the possible participation of inflammatory cells in pathogenesis of AMD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18577650     DOI: 10.1136/bjo.2007.129742

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  31 in total

1.  Early focal expression of the chemokine Ccl2 by Müller cells during exposure to damage-inducing bright continuous light.

Authors:  Matt Rutar; Riccardo Natoli; Krisztina Valter; Jan M Provis
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-04-12       Impact factor: 4.799

Review 2.  Can innate and autoimmune reactivity forecast early and advance stages of age-related macular degeneration?

Authors:  Grazyna Adamus
Journal:  Autoimmun Rev       Date:  2017-01-28       Impact factor: 9.754

3.  Immunological Aspects of Age-Related Macular Degeneration.

Authors:  Michael J Allingham; Anna Loksztejn; Scott W Cousins; Priyatham S Mettu
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

4.  Choriocapillaris vascular dropout related to density of drusen in human eyes with early age-related macular degeneration.

Authors:  Robert F Mullins; Micaela N Johnson; Elizabeth A Faidley; Jessica M Skeie; Jian Huang
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-03-01       Impact factor: 4.799

Review 5.  Complement activation and choriocapillaris loss in early AMD: implications for pathophysiology and therapy.

Authors:  S Scott Whitmore; Elliott H Sohn; Kathleen R Chirco; Arlene V Drack; Edwin M Stone; Budd A Tucker; Robert F Mullins
Journal:  Prog Retin Eye Res       Date:  2014-12-05       Impact factor: 21.198

6.  γδ T cells as a major source of IL-17 production during age-dependent RPE degeneration.

Authors:  Zhenyang Zhao; Pei Xu; Zuliang Jie; Yiqin Zuo; Bo Yu; Lynn Soong; Jiaren Sun; Yan Chen; Jiyang Cai
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-09-11       Impact factor: 4.799

7.  Autoimmune responses against photoreceptor antigens during retinal degeneration and their role in macrophage recruitment into retinas of RCS rats.

Authors:  Madison Kyger; Aneta Worley; Grazyna Adamus
Journal:  J Neuroimmunol       Date:  2012-10-27       Impact factor: 3.478

Review 8.  The role of lymphocytes and phagocytes in age-related macular degeneration (AMD).

Authors:  Verena Behnke; Anne Wolf; Thomas Langmann
Journal:  Cell Mol Life Sci       Date:  2020-01-02       Impact factor: 9.261

9.  Small interfering RNA-mediated suppression of Ccl2 in Müller cells attenuates microglial recruitment and photoreceptor death following retinal degeneration.

Authors:  Matt Rutar; Riccardo Natoli; Jan M Provis
Journal:  J Neuroinflammation       Date:  2012-09-19       Impact factor: 8.322

10.  Systemic immunotherapy delays photoreceptor cell loss and prevents vascular pathology in Royal College of Surgeons rats.

Authors:  Grazyna Adamus; Shaomei Wang; Madison Kyger; Aneta Worley; Bin Lu; Gregory G Burrows
Journal:  Mol Vis       Date:  2012-09-06       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.